Skip to main content

Table 4 Conditions that are associated with unfavorable outcome

From: Dramatic reduction of mortality in pneumococcal meningitis

 

GOS 5

GOS <5

OR (95 % CI)

P value 2003–2015

Gender (male/female)

7/16

12/20

1.37 (0.43–4.29)

0.775

Age (median ± SD)

60 ± 16.3

63 ± 12.6

 

0.152

Direct admission to tertiary center

56.5 %

18.8 %

0.18 (0.05–0.59)

0.005

Sinusitis

56.5 %

71.9 %

1.97 (0.63–6.07)

0.2644

Chronic underlying disease

21.7 %

53.1 %

4.08 (1.21–13.70)

0.026

Fever on admission

78.3 %

68.8 %

0.68 (0.20–2.40)

0.755

Neck stiffness on admission

91.3 %

75.0 %

0.38 (0.063–2.10)

0.442

Symptoms of meningitis before admission in days (median ± SD)

1 ± 2.65

1 ± 1.13

-

0.734

GCS on admission (median; minimum, maximum)

12; 3, 15

10; 3, 15

-

0.006

FND on admission

39.1 %

18.8 %

0.36 (0.11–1.22)

0.128

Leucocytes in serum (G/l) on admission (mean ± SD)

17.8 ± 7.74

18.67 ± 8.45

-

0.718

CRP on admission (mean ± SD)

14.73 ± 9.42

23.83 ± 11.54

-

0.007

Leucocytes in CSF/μl on admission (mean ± SD)

3623 ± 3898

3237 ± 4934

-

0.460

Protein in CSF in mg/dl on admission (mean ± SD)

432 ± 417

697 ± 107

-

0.094

Glucose in CSF in mg/dl on admission (mean ± SD)

48 ± 46

10 ± 16

-

<0.001

  1. SD standard deviation, GCS Glasgow Coma Score, FND focal neurologic deficit, CRP C-reactive protein, CSF cerebrospinal fluid